Scarica l'app Stockscreener
6.65
0.00%
0.00
Dopo l'orario di chiusura:
6.65
Precedente Chiudi:
$6.65
Aprire:
$6.54
Volume 24 ore:
478.30K
Relative Volume:
0.90
Capitalizzazione di mercato:
$361.83M
Reddito:
$250.01M
Utile/perdita netta:
$132.33M
Rapporto P/E:
2.9295
EPS:
2.27
Flusso di cassa netto:
$74.66M
1 W Prestazione:
-5.94%
1M Prestazione:
-5.54%
6M Prestazione:
-24.52%
1 anno Prestazione:
-0.89%
Intervallo 1D:
$6.4009
$6.69
Intervallo di 1 settimana:
$6.4009
$7.23
Portata 52W:
$5.71
$11.72
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Nome
Voyager Therapeutics Inc
Settore
Industria
Telefono
857-259-5340
Indirizzo
75 HAYDEN AVENUE, LEXINGTON, MA
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-05-10 | Iniziato | Truist | Buy |
| 2023-03-10 | Iniziato | Oppenheimer | Outperform |
| 2021-10-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-02-03 | Downgrade | Wedbush | Outperform → Neutral |
| 2020-12-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Iniziato | Oppenheimer | Outperform |
| 2018-11-15 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-09-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-02-02 | Iniziato | Morgan Stanley | Overweight |
| 2017-11-28 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-31 | Iniziato | Robert W. Baird | Outperform |
| 2017-10-27 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-23 | Reiterato | Stifel | Buy |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-28 | Ripresa | Stifel | Buy |
Mostra tutto
Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie
VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - StockTitan
Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World
StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat
How to Take Advantage of moves in (VYGR) - Stock Traders Daily
HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
Equities Analysts Offer Predictions for VYGR Q3 Earnings - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Strong-Buy at Leerink Partnrs - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Upgraded at Leerink Partnrs - MarketBeat
Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified - Simply Wall St
Leerink Partners Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics - Benzinga
The Manufacturers Life Insurance Company Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Gene Therapy in CNS Disorder Market Rapid Growth at Deep Value Price :Voyager Therapeutics, Spark Therapeutics, Novartis – IndiaPolitics.com - IndiaPolitics.com
(VYGR) Technical Pivots with Risk Controls - Stock Traders Daily
Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain - Yahoo Finance
Intracranial Therapeutic Market Rewriting its Growth Cycle |Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, – IndiaPolitics.com - IndiaPolitics.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Short Interest Update - MarketBeat
Voyager Therapeutics Inc (VYGR)’s Market Momentum: Closing Strong at 6.76, Down -4.52 - The Dwinnex
Monitoring Voyager Therapeutics Inc (VYGR) after recent insider movements - Knox Daily
Analyzing the Impact of Earnings Reports on Voyager Therapeutics Inc Inc. (VYGR) Price Performance - The InvestChronicle
Nothing is Better Than Voyager Therapeutics Inc (VYGR) stock at the moment - SETE News
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Holdings Lessened by Dimensional Fund Advisors LP - MarketBeat
Are Voyager Therapeutics Inc (VYGR) shares a good deal now? - US Post News
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - Yahoo Finance
Strong week for Voyager Therapeutics (NASDAQ:VYGR) shareholders doesn't alleviate pain of five-year loss - Simply Wall St
AQR Capital Management LLC Sells 291,259 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k By Investing.com - Investing.com Australia
Voyager Therapeutics Inc [VYGR] stock for 34,914 USD was sold by Fahey Sandell Jacquelyn - Knox Daily
Voyager Therapeutics Inc (VYGR) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
What is the investor’s view on Voyager Therapeutics Inc (VYGR)? - US Post News
(VYGR) Technical Data - Stock Traders Daily
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Insider Sells $34,914.18 in Stock - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k - Investing.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M - MSN
Armistice Capital LLC Raises Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics stock hits 52-week low at $5.95 By Investing.com - Investing.com Australia
Baird maintains Outperform rating on Voyager Therapeutics stock By Investing.com - Investing.com Canada
Closing Figures: Voyager Therapeutics Inc (VYGR)’s Negative Finish at 6.04, Down -0.98 - The Dwinnex
Voyager Therapeutics stock hits 52-week low at $5.95 - Investing.com
Great Point Partners LLC Invests $12.67 Million in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
What is Voyager Therapeutics Inc (VYGR) Stock Return on Shareholders’ Capital? - SETE News
(VYGR) Trading Report - Stock Traders Daily
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):